Categories Earnings, Health Care

Infographic: Biogen (BIIB) Q1 2020 Earnings Results

Biogen Inc. (NASDAQ: BIIB) reported its financial results for the quarter ended March 31, 2020 today.

Biogen posted a 1% decline in earnings for the first quarter of 2020 due to higher costs and expenses despite a 1% rise in the top-line. The company continued to develop and expand its pipeline, including making good progress toward the US regulatory filing for aducanumab, as well as bolstering its efforts in gene therapy through a collaboration with Sangamo.

Biogen (BIIB) Q1 2020 earnings review

The company believes that the magnitude and uncertainty surrounding the COVID-19 pandemic clearly introduce unanticipated and potentially unquantifiable risks to its business and results over the near-term. While Biogen does expect there will be some impact on timelines for certain of its clinical programs, it still expects the vast majority of the 10 remaining near-term readouts to occur before the end of 2021.

Past Performance

Most Popular

Earnings Preview: Salesforce (CRM) likely to report higher Q4 revenues and profit

Customer relationship management platform Salesforce, Inc. (NYSE: CRM) will be publishing its fourth-quarter 2024 results next week, amid expectations for a year-over-year increase in revenues and earnings. Of late, the

What to expect when Macy’s (M) reports Q4 2023 earnings results

Shares of Macy’s, Inc. (NYSE: M) rose over 2% on Friday. The stock has gained 31% over the past three months. The retailer is scheduled to report its fourth quarter

Earnings Summary: Warner Bros. Discovery (WBD) reports Q4 2023 results

Warner Bros. Discovery (NASDAQ: WBD), a leading media and entertainment company, has reported financial results for the fourth quarter of 2023. Q4 revenue was $10.28 billion, down 7% from the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top